End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,975 IDR | +3.57% | +1.92% | +51.90% |
06:21am | Chandra Asri purchase of Shell Singapore refinery brings scale, risk | RE |
May. 09 | Chandra Asri purchase of Shell Singapore refinery brings scale, risk | RE |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company has insufficient levels of profitability.
- With an expected P/E ratio at 1160.84 and 567.53 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+51.90% | 43.02B | B | ||
+5.93% | 105B | A- | ||
-4.19% | 63.99B | A- | ||
+17.44% | 39.28B | B | ||
+6.93% | 33.09B | A- | ||
+12.84% | 20.23B | B- | ||
+15.64% | 17.39B | C+ | ||
+22.55% | 15.45B | B- | ||
+7.34% | 15.07B | B | ||
-14.29% | 13.77B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- TPIA Stock
- Ratings PT Chandra Asri Pacific Tbk